ClearBridge Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $65.1M | Buy |
|
|||||
|
2025
Q2 | $53.5M | Sell |
|
|||||
|
2025
Q1 | $104M | Sell |
|
|||||
|
2024
Q4 | $143M | Sell |
|
|||||
|
2024
Q3 | $215M | Sell |
|
|||||
|
2024
Q2 | $283M | Sell |
|
|||||
|
2024
Q1 | $410M | Buy |
|
|||||
|
2023
Q4 | $347M | Sell |
|
|||||
|
2023
Q3 | $342M | Sell |
|
|||||
|
2023
Q2 | $368M | Buy |
|
|||||
|
2023
Q1 | $284M | Buy |
|
|||||
|
2022
Q4 | $299M | Sell |
|
|||||
|
2022
Q3 | $285M | Sell |
|
|||||
|
2022
Q2 | $314M | Buy |
|
|||||
|
2022
Q1 | $389M | Buy |
|
|||||
|
2021
Q4 | $402M | Buy |
|
|||||
|
2021
Q3 | $218M | Buy |
|
|||||
|
2021
Q2 | $145M | Buy |
|
|||||
|
2021
Q1 | $83.5M | Buy |
|
|||||
|
2020
Q4 | $56.5M | Buy |
|
|||||
|
2020
Q3 | $30.6M | Buy |
|